Sorafenib, a multikinase inhibitor, is effective in vitro against non-Hodgkin lymphoma and synergizes with the mTOR inhibitor rapamycin.
about
Are we ready to stratify treatment for diffuse large B-cell lymphoma using molecular hallmarks?Modulation of Autophagy by Sorafenib: Effects on Treatment ResponseSorafenib inhibits lymphoma xenografts by targeting MAPK/ERK and AKT pathways in tumor and vascular cells.Growth-factor-driven rescue to receptor tyrosine kinase (RTK) inhibitors through Akt and Erk phosphorylation in pediatric low grade astrocytoma and ependymomaThe mTORC1 inhibitor everolimus has antitumor activity in vitro and produces tumor responses in patients with relapsed T-cell lymphoma.Interactions of everolimus and sorafenib in pancreatic cancer cells.Synergistic interactions between sorafenib and everolimus in pancreatic cancer xenografts in mice.Targeting the vascular endothelial growth factor in hematologic malignancies.Managing Hodgkin lymphoma relapsing after autologous hematopoietic cell transplantation: a not-so-good cancer after all!NRAS mutations in cutaneous T cell lymphoma (CTCL) sensitize tumors towards treatment with the multikinase inhibitor Sorafenib.Comparative oncology DNA sequencing of canine T cell lymphoma via human hotspot panel.
P2860
Q24597424-7CD2BC14-4833-43C2-AED4-C7BB7072C4C3Q26745320-694B97DF-50E2-46DF-8938-8230FC2C1EDEQ34689078-9E2B3361-E9D5-462D-9172-FC5D087A9997Q35583984-31503D56-2768-4329-8DF2-D2D768FFE49AQ35859219-3C98D06B-4463-46B4-B0CA-CB1D976954EFQ36502419-EF4ABA47-5C2B-4E5E-8285-BA5F59EC02A3Q37119137-E5B8F659-04A6-4F05-90C0-92523538D4ACQ38038645-BFA0B2D2-E826-4289-AFAB-F056D9006C51Q38179975-ED75E040-E01C-4C7D-BF2A-E5933D3480B0Q41233629-D06DC255-203E-471A-9570-C42F78044E66Q55135232-E20D3B8D-BCFA-4413-B509-FED5FC509C71
P2860
Sorafenib, a multikinase inhibitor, is effective in vitro against non-Hodgkin lymphoma and synergizes with the mTOR inhibitor rapamycin.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Sorafenib, a multikinase inhib ...... the mTOR inhibitor rapamycin.
@ast
Sorafenib, a multikinase inhib ...... the mTOR inhibitor rapamycin.
@en
type
label
Sorafenib, a multikinase inhib ...... the mTOR inhibitor rapamycin.
@ast
Sorafenib, a multikinase inhib ...... the mTOR inhibitor rapamycin.
@en
prefLabel
Sorafenib, a multikinase inhib ...... the mTOR inhibitor rapamycin.
@ast
Sorafenib, a multikinase inhib ...... the mTOR inhibitor rapamycin.
@en
P2093
P2860
P356
P1476
Sorafenib, a multikinase inhib ...... h the mTOR inhibitor rapamycin
@en
P2093
Alex A Adjei
Jessica L Haug
Linda E Wellik
Michael Timm
Shaji Kumar
Teresa K Kimlinger
Thomas E Witzig
Timothy Halling
Vijay Ramakrishnan
P2860
P304
P356
10.1002/AJH.22263
P577
2011-12-21T00:00:00Z